Charles Cherington 13D and 13G filings for Ernexa Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-11 8:39 pm Purchase | 2025-06-09 | 13D | Ernexa Therapeutics Inc. ERNA | Charles Cherington | 2,779,385 37.900% | 1,417,209 (+104.04%) | Filing |
| 2025-04-04 10:55 am Purchase | 2025-04-02 | 13D | Ernexa Therapeutics Inc. ERNA | Charles Cherington | 1,362,176 32.800% | 252,697 (+22.78%) | Filing |
| 2025-03-05 5:55 pm Purchase | 2024-10-29 | 13D | Ernexa Therapeutics Inc. ERNA | Charles Cherington | 1,109,479 32.380% | 1,109,479 (New Position) | Filing |